Fig. 1From: Molecular targets of Yangyin Fuzheng Jiedu Prescription in the treatment of hepatocellular carcinoma based on network pharmacology analysisKaplan–Meier analysis. Kaplan–Meier analysis for the 5-year cumulative survival rate between patients in the YFJP group (n = 159) and non-YFJP group (n = 318)Back to article page